Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
life sciences
national blog main
boston blog main
clinical trials
san francisco blog main
boston top stories
national top stories
startups
cancer
fda
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
bain capital
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
crispr therapeutics
detroit blog main
detroit top stories
drugs
eli lilly
european society for medical oncology
indiana blog main
indiana top stories
investing
loxo oncology
mirati therapeutics
national
nonalcoholic steatohepatitis
orbimed advisors
pfizer
president trump
What
biotech
10
×
drug
10
×
new
cancer
companies
ipo
medicines
research
annual
attention
bio
bring
called
clinical
days
develop
drugs
investment
lead
leading
medical
million
raised
ready
roundup
startups
therapeutics
today
turned
activity
ahead
algorithms
alzheimer’s
ambien
american
analysis
announce
approved
approves
asco
Language
unset
Current search:
drug
×
biotech
×
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
@techcrunch.com
9 years ago
M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF
@theverge.com
9 years ago
FDA approves the first generic copy of a costly biotech drug